Skip to main
DOCS

Doximity (DOCS) Stock Forecast & Price Target

Doximity (DOCS) Analyst Ratings

Based on 21 analyst ratings
Buy
Strong Buy 29%
Buy 29%
Hold 43%
Sell 0%
Strong Sell 0%

Bulls say

Doximity is well-positioned to continue growing in the HCP digital marketing space, as it has demonstrated strong ability to gain market share and outperform the industry growth. With its diverse product offerings and strong partnerships with medical professionals, pharmaceutical companies, and health systems, Doximity has a strong revenue base and potential for future growth. The company's investments in AI tools and other new technologies show its commitment to remain a leader in the market. While there may be some headwinds in the short term due to uncertainty in the pharmaceutical industry, we believe Doximity's strong fundamentals make it a solid investment option for the future.

Bears say

Doximity is facing increased regulatory uncertainties and slower-than-expected growth, leading to a decrease in its price target to $55. Despite beating revenue and earnings estimates in Q3, the company narrowed its full-year guidance and saw a slowdown in top customers' spending. The competition in the market may also pose a risk to Doximity's future growth and financials.

Doximity (DOCS) has been analyzed by 21 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 29% recommend Buy, 43% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Doximity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Doximity (DOCS) Forecast

Analysts have given Doximity (DOCS) a Buy based on their latest research and market trends.

According to 21 analysts, Doximity (DOCS) has a Buy consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $31.48, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $31.48, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Doximity (DOCS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.